Lori McKenna Gorski
Directeur/Membre du Conseil chez Our Odyssey, Inc.
Profil
Lori McKenna Gorski is currently the Director at Our Odyssey, Inc. She has previously worked as the Associate Director-Corporate Communications at Genzyme Corp., Global Head-Patient Advocacy at Cyclo Therapeutics, Inc., Head-Media Relations at Radius Health, Inc., and Head-Media Relations at Thermo Fisher Scientific, Inc. Ms. Gorski received her undergraduate degree from Boston College in 1996.
Postes actifs de Lori McKenna Gorski
| Sociétés | Poste | Début |
|---|---|---|
| Our Odyssey, Inc. | Directeur/Membre du Conseil | - |
Anciens postes connus de Lori McKenna Gorski
| Sociétés | Poste | Fin |
|---|---|---|
| CYCLO THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Public Communications Contact | - |
| RADIUS HEALTH, INC. | Public Communications Contact | - |
| THERMO FISHER SCIENTIFIC | Public Communications Contact | - |
Formation de Lori McKenna Gorski
| Boston College | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CYCLO THERAPEUTICS, INC. | Health Technology |
| THERMO FISHER SCIENTIFIC | Health Technology |
| Entreprise privées | 3 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
| Our Odyssey, Inc. |
